Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of IRS/STAT3 dual modulators and anti-cancer agents for treating cancer

Combinations of IRS/STAT3 dual modulators and anti-cancer agents for treating cancer

US Patent 12201592 · Granted Jan 21, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combinations of IRS/Stat3 dual modulators and anti-cancer agents for treating ca2021
Combinations of IRS/Stat3 dual modulators and anti-cancer agents for treating ca2021
Combinations of IRS/Stat3 dual modulators and anti-cancer agents for treating ca2021
IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative2019
Pro-angiogenic peptides and peptide conjugates2018
IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative2017
Lipid biomarkers for stable and unstable heart disease2016
Lipid biomarkers for stable and unstable heart disease2015
2-(2-phenylethenyl) 1,3-benzodiazepine derivatives useful for the treatment of c2015
Modulators of protein kinase signaling2014
Protein kinase C inhibitors for prevention of insulin resistance and type 2 diab2013
Protein kinase modulators and therapeutic uses thereof2011